Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Aclaris Therapeutics, Inc. (ACRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/08/2020 |
8-K
| Appointed a new director |
| 07/03/2019 |
8-K
| Appointed a new director |
| 04/25/2018 |
8-K
| Quarterly results |
| 08/09/2017 |
8-K
| Appointed a new director|
Docs:
|
"Aclaris Announces Appointment of Andrew Schiff to Board of Directors Malvern, PA – August 9, 2017 – Aclaris Therapeutics, Inc. , a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology, today announced the appointment of Andrew Schiff, Managing Partner of Aisling Capital, to its board of directors, effective August 9, 2017." |
|
| 01/26/2017 |
8-K
| Form 8-K - Current report |
| 08/04/2016 |
8-K
| Appointed a new director |
|
|